Skip to main content

Lassen Therapeutics

San Diego, United States

Lassen Therapeutics develops antibody biotherapeutics to help improve the lives of patients suffering from serious diseases.

$85.0M raised
Dec 2023
Series B

Top Investors

Catalio Capital ManagementLongitude CapitalFrazier Healthcare PartnersLongwood FundFrazier Life Sciences

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Lassen Therapeutics

How much funding has Lassen Therapeutics raised?
Lassen Therapeutics has raised $85.0M in total funding. The most recent round was Series B. The last funding was announced in December 2023.
Who are Lassen Therapeutics's investors?
Lassen Therapeutics's investors include Catalio Capital Management, Longitude Capital, Frazier Healthcare Partners, Longwood Fund, Frazier Life Sciences.
Where is Lassen Therapeutics headquartered?
Lassen Therapeutics is headquartered in San Diego, United States.
What does Lassen Therapeutics do?
Lassen Therapeutics develops antibody biotherapeutics to help improve the lives of patients suffering from serious diseases.
What stage is Lassen Therapeutics at?
Lassen Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Lassen Therapeutics — Funding & Investors." VCBacked, December 19, 2023, https://www.vcbacked.co/company/lassen-therapeutics. Accessed June 17, 2026.
APA
VCBacked. (2023). Lassen Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/lassen-therapeutics
Wikipedia (cite web)
{{cite web |title=Lassen Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/lassen-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .